Showing results (511-520 of 686) with videos related to

Sort By:
Pageof 69
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 5, 2014
Colonic inflammation and secondary bile acids in alcoholic cirrhosisGenta Kakiyama, Phillip B Hylemon, Huiping Zhou, et al.
Nature Medicine|January 27, 2025
Long-term liver outcomes after metabolic surgery in compensated cirrhosis due to metabolic dysfunction-associated steatohepatitisAli Aminian, Abdullah Aljabri, Sarah Wang, et al.
Alimentary Pharmacology & Therapeutics|October 25, 2023
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver ForumMelissa Palmer, David E Kleiner, Zachary Goodman, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Cholangiocyte RUNX1 Orchestrates Fibrogenic and Inflammatory Signaling to Drive Biliary FibrosisSayed Obaidullah Aseem, Jing Wang, Ahmed Younis, et al.
Journal of Hepatology|August 15, 2012
Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosisJasmohan S Bajaj, Vishwadeep Ahluwalia, James B Wade, et al.
Journal of Clinical Gastroenterology|January 9, 2022
Derivation and Validation of a Model to Predict Clinically Significant Portal Hypertension Using Transient Elastography and FIB-4Bubu A Banini, Samarth Patel, Jonathan W Yu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2010
An explicit quality indicator set for measurement of quality of care in patients with cirrhosisFasiha Kanwal, Jennifer Kramer, Steven M Asch, et al.
Hepatology (Baltimore, Md.)|November 8, 2024
Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trialBenjamin J Bruno, Joshua C Weavil, Jonathan Ogle, et al.
Hepatology (Baltimore, Md.)|February 8, 2013
The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathyJasmohan S Bajaj, Leroy R Thacker, Douglas M Heuman, et al.
International Journal of Clinical Practice|November 29, 2013
GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysisR Lencioni, M Kudo, S-L Ye, et al.
Pageof 69